View ValuationValiantLtd 将来の成長Future 基準チェック /26ValiantLtd利益と収益がそれぞれ年間26.9%と12.7%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に7.5% 26.6%なると予測されています。主要情報26.9%収益成長率26.64%EPS成長率Chemicals 収益成長30.6%収益成長率12.7%将来の株主資本利益率7.55%アナリストカバレッジLow最終更新日27 Apr 2026今後の成長に関する最新情報Price Target Changed • Feb 03Price target increased by 16% to CN¥18.67Up from CN¥16.10, the current price target is an average from 3 analysts. New target price is 12% above last closing price of CN¥16.73. Stock is up 65% over the past year. The company is forecast to post earnings per share of CN¥0.45 for next year compared to CN¥0.26 last year.Major Estimate Revision • Aug 23Consensus EPS estimates increase by 17%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate increased from CN¥0.454 to CN¥0.532. Revenue forecast steady at CN¥4.16b. Net income forecast to grow 134% next year vs 48% growth forecast for Chemicals industry in China. Consensus price target up from CN¥14.17 to CN¥15.60. Share price rose 7.4% to CN¥13.99 over the past week.Price Target Changed • Aug 22Price target increased by 7.4% to CN¥14.77Up from CN¥13.75, the current price target is an average from 3 analysts. New target price is 5.6% above last closing price of CN¥13.99. Stock is up 71% over the past year. The company is forecast to post earnings per share of CN¥0.62 for next year compared to CN¥0.26 last year.Major Estimate Revision • May 01Consensus revenue estimates fall by 11%The consensus outlook for revenues in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from CN¥4.73b to CN¥4.19b. EPS estimate fell from CN¥0.669 to CN¥0.528 per share. Net income forecast to grow 138% next year vs 49% growth forecast for Chemicals industry in China. Consensus price target up from CN¥13.75 to CN¥14.13. Share price was steady at CN¥10.92 over the past week.Major Estimate Revision • Nov 23Consensus EPS estimates increase by 26%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has improved. 2024 revenue forecast increased from CN¥3.70b to CN¥3.81b. EPS estimate increased from CN¥0.45 to CN¥0.566 per share. Net income forecast to grow 21% next year vs 53% growth forecast for Chemicals industry in China. Consensus price target of CN¥12.75 unchanged from last update. Share price fell 2.7% to CN¥10.51 over the past week.Major Estimate Revision • Aug 29Consensus revenue estimates fall by 15%The consensus outlook for revenues in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥4.86b to CN¥4.15b. EPS estimate fell from CN¥0.908 to CN¥0.561 per share. Net income forecast to grow 21% next year vs 45% growth forecast for Chemicals industry in China. Consensus price target down from CN¥18.25 to CN¥13.75. Share price rose 4.4% to CN¥8.35 over the past week.すべての更新を表示Recent updatesReported Earnings • Apr 25First quarter 2026 earnings released: EPS: CN¥0.10 (vs CN¥0.09 in 1Q 2025)First quarter 2026 results: EPS: CN¥0.10 (up from CN¥0.09 in 1Q 2025). Revenue: CN¥1.02b (up 18% from 1Q 2025). Net income: CN¥87.8m (up 10.0% from 1Q 2025). Profit margin: 8.7% (down from 9.3% in 1Q 2025). Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.お知らせ • Apr 25Valiant Co.,Ltd, Annual General Meeting, May 21, 2026Valiant Co.,Ltd, Annual General Meeting, May 21, 2026, at 14:00 China Standard Time. Location: The Company's Meeting Room, Yantai, Shandong Chinaお知らせ • Mar 31Valiant Co.,Ltd to Report Q1, 2026 Results on Apr 25, 2026Valiant Co.,Ltd announced that they will report Q1, 2026 results on Apr 25, 2026Price Target Changed • Feb 03Price target increased by 16% to CN¥18.67Up from CN¥16.10, the current price target is an average from 3 analysts. New target price is 12% above last closing price of CN¥16.73. Stock is up 65% over the past year. The company is forecast to post earnings per share of CN¥0.45 for next year compared to CN¥0.26 last year.お知らせ • Dec 31Valiant Co.,Ltd to Report Fiscal Year 2025 Results on Apr 25, 2026Valiant Co.,Ltd announced that they will report fiscal year 2025 results on Apr 25, 2026Reported Earnings • Oct 30Third quarter 2025 earnings: EPS and revenues miss analyst expectationsThird quarter 2025 results: EPS: CN¥0.099 (up from CN¥0.089 in 3Q 2024). Revenue: CN¥956.4m (up 19% from 3Q 2024). Net income: CN¥87.5m (up 8.4% from 3Q 2024). Profit margin: 9.1% (in line with 3Q 2024). Revenue missed analyst estimates by 9.9%. Earnings per share (EPS) also missed analyst estimates by 22%. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.お知らせ • Sep 30Valiant Co.,Ltd to Report Q3, 2025 Results on Oct 27, 2025Valiant Co.,Ltd announced that they will report Q3, 2025 results on Oct 27, 2025Reported Earnings • Aug 24Second quarter 2025 earnings: EPS exceeds analyst expectationsSecond quarter 2025 results: EPS: CN¥0.14 (up from CN¥0.12 in 2Q 2024). Revenue: CN¥1.01b (down 1.0% from 2Q 2024). Net income: CN¥138.3m (up 18% from 2Q 2024). Profit margin: 14% (up from 12% in 2Q 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 53%. Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 34% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.Major Estimate Revision • Aug 23Consensus EPS estimates increase by 17%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate increased from CN¥0.454 to CN¥0.532. Revenue forecast steady at CN¥4.16b. Net income forecast to grow 134% next year vs 48% growth forecast for Chemicals industry in China. Consensus price target up from CN¥14.17 to CN¥15.60. Share price rose 7.4% to CN¥13.99 over the past week.Price Target Changed • Aug 22Price target increased by 7.4% to CN¥14.77Up from CN¥13.75, the current price target is an average from 3 analysts. New target price is 5.6% above last closing price of CN¥13.99. Stock is up 71% over the past year. The company is forecast to post earnings per share of CN¥0.62 for next year compared to CN¥0.26 last year.お知らせ • Jul 02Valiant Co.,Ltd to Report First Half, 2025 Results on Aug 22, 2025Valiant Co.,Ltd announced that they will report first half, 2025 results on Aug 22, 2025Declared Dividend • Jun 01Dividend reduced to CN¥0.10Dividend of CN¥0.10 is 67% lower than last year. Ex-date: 6th June 2025 Payment date: 6th June 2025 Dividend yield will be 0.9%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (42% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 3.3% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 139% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Major Estimate Revision • May 01Consensus revenue estimates fall by 11%The consensus outlook for revenues in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from CN¥4.73b to CN¥4.19b. EPS estimate fell from CN¥0.669 to CN¥0.528 per share. Net income forecast to grow 138% next year vs 49% growth forecast for Chemicals industry in China. Consensus price target up from CN¥13.75 to CN¥14.13. Share price was steady at CN¥10.92 over the past week.Board Change • Apr 30High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Chairman of the Supervisory Board Lei Zhang was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.お知らせ • Apr 27Valiant Co.,Ltd (SZSE:002643) announces an Equity Buyback for CNY 200 million worth of its shares.Valiant Co.,Ltd (SZSE:002643) announces a share repurchase program. Under the program, the company will repurchase up to CNY 200 million worth of class A common shares. The shares will be repurchased at a purchase price of CNY 16.55 per share. The purpose of the program is to reduce the company's registered capital. The program will be valid for 12 months.Reported Earnings • Apr 25First quarter 2025 earnings released: EPS: CN¥0.09 (vs CN¥0.11 in 1Q 2024)First quarter 2025 results: EPS: CN¥0.09 (down from CN¥0.11 in 1Q 2024). Revenue: CN¥861.2m (down 8.2% from 1Q 2024). Net income: CN¥79.9m (down 19% from 1Q 2024). Profit margin: 9.3% (down from 11% in 1Q 2024). Revenue is forecast to grow 23% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings.お知らせ • Apr 25Valiant Co.,Ltd, Annual General Meeting, May 21, 2025Valiant Co.,Ltd, Annual General Meeting, May 21, 2025, at 14:00 China Standard Time. Location: The Company's Meeting Room, Yantai, Shandong ChinaBuy Or Sell Opportunity • Apr 04Now 21% undervaluedOver the last 90 days, the stock has risen 3.7% to CN¥10.99. The fair value is estimated to be CN¥13.93, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 4.7% over the last 3 years. Earnings per share has declined by 6.5%. Revenue is forecast to grow by 36% in 2 years. Earnings are forecast to grow by 49% in the next 2 years.お知らせ • Mar 31Valiant Co.,Ltd to Report Q1, 2025 Results on Apr 25, 2025Valiant Co.,Ltd announced that they will report Q1, 2025 results on Apr 25, 2025分析記事 • Mar 25Valiant Co.,Ltd's (SZSE:002643) Share Price Is Matching Sentiment Around Its EarningsValiant Co.,Ltd's ( SZSE:002643 ) price-to-earnings (or "P/E") ratio of 21.4x might make it look like a buy right now...分析記事 • Mar 07There Are Reasons To Feel Uneasy About ValiantLtd's (SZSE:002643) Returns On CapitalIf you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...分析記事 • Feb 21We Think ValiantLtd (SZSE:002643) Is Taking Some Risk With Its DebtDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Buy Or Sell Opportunity • Feb 13Now 20% undervaluedThe stock has been flat over the last 90 days, currently trading at CN¥10.79. The fair value is estimated to be CN¥13.55, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 4.7% over the last 3 years. Earnings per share has declined by 6.5%. Revenue is forecast to grow by 36% in 2 years. Earnings are forecast to grow by 49% in the next 2 years.Valuation Update With 7 Day Price Move • Jan 03Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥10.60, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 18x in the Chemicals industry in China. Total loss to shareholders of 48% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥14.59 per share.Buy Or Sell Opportunity • Jan 02Now 24% undervaluedOver the last 90 days, the stock has risen 9.0% to CN¥11.30. The fair value is estimated to be CN¥14.79, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 4.7% over the last 3 years. Earnings per share has declined by 6.5%. Revenue is forecast to grow by 36% in 2 years. Earnings are forecast to grow by 49% in the next 2 years.お知らせ • Dec 31Valiant Co.,Ltd to Report Fiscal Year 2024 Results on Apr 25, 2025Valiant Co.,Ltd announced that they will report fiscal year 2024 results on Apr 25, 2025分析記事 • Dec 18Calculating The Fair Value Of Valiant Co.,Ltd (SZSE:002643)Key Insights Using the 2 Stage Free Cash Flow to Equity, ValiantLtd fair value estimate is CN¥14.68 Current share price...分析記事 • Dec 04Valiant Co.,Ltd's (SZSE:002643) Shares Bounce 31% But Its Business Still Trails The MarketValiant Co.,Ltd ( SZSE:002643 ) shares have continued their recent momentum with a 31% gain in the last month alone...Valuation Update With 7 Day Price Move • Dec 03Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥12.42, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 20x in the Chemicals industry in China. Total loss to shareholders of 44% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥14.52 per share.分析記事 • Nov 26ValiantLtd (SZSE:002643) Could Be Struggling To Allocate CapitalIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Major Estimate Revision • Nov 23Consensus EPS estimates increase by 26%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has improved. 2024 revenue forecast increased from CN¥3.70b to CN¥3.81b. EPS estimate increased from CN¥0.45 to CN¥0.566 per share. Net income forecast to grow 21% next year vs 53% growth forecast for Chemicals industry in China. Consensus price target of CN¥12.75 unchanged from last update. Share price fell 2.7% to CN¥10.51 over the past week.Buy Or Sell Opportunity • Nov 13Now 20% undervaluedOver the last 90 days, the stock has risen 28% to CN¥11.55. The fair value is estimated to be CN¥14.47, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 4.7% over the last 3 years. Earnings per share has declined by 6.5%. Revenue is forecast to grow by 33% in 2 years. Earnings are forecast to grow by 63% in the next 2 years.分析記事 • Nov 05ValiantLtd's (SZSE:002643) Shareholders Have More To Worry About Than Only Soft EarningsThe market wasn't impressed with the soft earnings from Valiant Co.,Ltd ( SZSE:002643 ) recently. We did some analysis...Reported Earnings • Oct 30Third quarter 2024 earnings: EPS and revenues miss analyst expectationsThird quarter 2024 results: EPS: CN¥0.089 (down from CN¥0.20 in 3Q 2023). Revenue: CN¥806.3m (down 27% from 3Q 2023). Net income: CN¥80.7m (down 57% from 3Q 2023). Profit margin: 10.0% (down from 17% in 3Q 2023). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 23%. Earnings per share (EPS) also missed analyst estimates by 50%. Revenue is forecast to grow 19% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has fallen by 20% per year, which means it is performing significantly worse than earnings.Buy Or Sell Opportunity • Oct 11Now 20% undervaluedOver the last 90 days, the stock has risen 2.1% to CN¥9.77. The fair value is estimated to be CN¥12.28, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue is forecast to grow by 33% in 2 years. Earnings are forecast to grow by 51% in the next 2 years.分析記事 • Oct 08Valiant Co.,Ltd's (SZSE:002643) Shares Bounce 40% But Its Business Still Trails The MarketValiant Co.,Ltd ( SZSE:002643 ) shares have had a really impressive month, gaining 40% after a shaky period beforehand...お知らせ • Sep 30Valiant Co.,Ltd to Report Q3, 2024 Results on Oct 30, 2024Valiant Co.,Ltd announced that they will report Q3, 2024 results on Oct 30, 2024Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥9.43, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 47% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥12.08 per share.分析記事 • Sep 05Are Investors Undervaluing Valiant Co.,Ltd (SZSE:002643) By 30%?Key Insights Using the 2 Stage Free Cash Flow to Equity, ValiantLtd fair value estimate is CN¥12.10 ValiantLtd's...Major Estimate Revision • Aug 29Consensus revenue estimates fall by 15%The consensus outlook for revenues in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥4.86b to CN¥4.15b. EPS estimate fell from CN¥0.908 to CN¥0.561 per share. Net income forecast to grow 21% next year vs 45% growth forecast for Chemicals industry in China. Consensus price target down from CN¥18.25 to CN¥13.75. Share price rose 4.4% to CN¥8.35 over the past week.Price Target Changed • Aug 27Price target decreased by 9.2% to CN¥16.63Down from CN¥18.31, the current price target is an average from 4 analysts. New target price is 107% above last closing price of CN¥8.03. Stock is down 54% over the past year. The company is forecast to post earnings per share of CN¥0.90 for next year compared to CN¥0.84 last year.Reported Earnings • Aug 22Second quarter 2024 earnings: EPS and revenues miss analyst expectationsSecond quarter 2024 results: EPS: CN¥0.12 (down from CN¥0.24 in 2Q 2023). Revenue: CN¥1.02b (down 2.2% from 2Q 2023). Net income: CN¥116.9m (down 45% from 2Q 2023). Profit margin: 12% (down from 20% in 2Q 2023). The decrease in margin was primarily driven by higher expenses. Revenue missed analyst estimates by 26%. Earnings per share (EPS) also missed analyst estimates by 46%. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has fallen by 27% per year, which means it is significantly lagging earnings.分析記事 • Aug 19Lacklustre Performance Is Driving Valiant Co.,Ltd's (SZSE:002643) Low P/EWith a price-to-earnings (or "P/E") ratio of 11.7x Valiant Co.,Ltd ( SZSE:002643 ) may be sending very bullish signals...分析記事 • Jul 18We Think ValiantLtd (SZSE:002643) Can Stay On Top Of Its DebtWarren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...お知らせ • Jun 29Valiant Co.,Ltd to Report First Half, 2024 Results on Aug 22, 2024Valiant Co.,Ltd announced that they will report first half, 2024 results on Aug 22, 2024分析記事 • Jun 21Return Trends At ValiantLtd (SZSE:002643) Aren't AppealingTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Amongst other things...分析記事 • Jun 02ValiantLtd (SZSE:002643) Has Announced That It Will Be Increasing Its Dividend To CN¥0.30Valiant Co.,Ltd ( SZSE:002643 ) will increase its dividend on the 6th of June to CN¥0.30, which is 1.7% higher than...Declared Dividend • Jun 01Dividend of CN¥0.30 announcedShareholders will receive a dividend of CN¥0.30. Ex-date: 6th June 2024 Payment date: 6th June 2024 Dividend yield will be 2.6%, which is about the same as the industry average. Sustainability & Growth Dividend is covered by earnings (39% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 15% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 61% over the next 3 years, which should provide support to the dividend and adequate earnings cover.お知らせ • May 31Valiant Co.,Ltd Announces 2023 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 06 June 2024Valiant Co.,Ltd announced 2023 final profit distribution plan to be implemented (A shares) of Cash dividend/10 shares (tax included) is CNY 3.00000000, Record date is 05 June 2024, Ex-date: 06 June 2024, Payment date is 06 June 2024.Major Estimate Revision • May 23Consensus EPS estimates increase by 14%The consensus outlook for fiscal year 2024 has been updated. 2024 consensus EPS increased from CN¥0.831 to CN¥0.947. Revenues were reaffirmed at CN¥4.86b. Net income forecast to grow 36% next year vs 52% growth forecast for Chemicals industry in China. Consensus price target broadly unchanged at CN¥18.25. Share price was steady at CN¥11.44 over the past week.分析記事 • Apr 26Solid Earnings May Not Tell The Whole Story For ValiantLtd (SZSE:002643)The stock price didn't jump after Valiant Co.,Ltd ( SZSE:002643 ) posted decent earnings last week. We did some digging...Major Estimate Revision • Apr 26Consensus revenue estimates fall by 13%The consensus outlook for revenues in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥5.58b to CN¥4.86b. EPS estimate fell from CN¥1.04 to CN¥0.831 per share. Net income forecast to grow 21% next year vs 39% growth forecast for Chemicals industry in China. Consensus price target down from CN¥20.64 to CN¥18.31. Share price fell 8.4% to CN¥11.31 over the past week.分析記事 • Apr 23What Does The Future Hold For Valiant Co.,Ltd (SZSE:002643)? These Analysts Have Been Cutting Their EstimatesThe analysts covering Valiant Co.,Ltd ( SZSE:002643 ) delivered a dose of negativity to shareholders today, by making a...Price Target Changed • Apr 22Price target decreased by 7.3% to CN¥19.14Down from CN¥20.64, the current price target is an average from 4 analysts. New target price is 72% above last closing price of CN¥11.12. Stock is down 36% over the past year. The company is forecast to post earnings per share of CN¥0.98 for next year compared to CN¥0.84 last year.お知らせ • Apr 21Valiant Co.,Ltd, Annual General Meeting, May 16, 2024Valiant Co.,Ltd, Annual General Meeting, May 16, 2024, at 14:00 China Standard Time. Location: The Company's Meeting Room, Yantai, Shandong ChinaReported Earnings • Apr 20First quarter 2024 earnings released: EPS: CN¥0.11 (vs CN¥0.19 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.11 (down from CN¥0.19 in 1Q 2023). Revenue: CN¥937.9m (down 9.2% from 1Q 2023). Net income: CN¥98.3m (down 44% from 1Q 2023). Profit margin: 11% (down from 17% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 23% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.Price Target Changed • Apr 08Price target decreased by 12% to CN¥20.64Down from CN¥23.54, the current price target is an average from 4 analysts. New target price is 58% above last closing price of CN¥13.02. Stock is down 26% over the past year. The company is forecast to post earnings per share of CN¥0.85 for next year compared to CN¥0.79 last year.お知らせ • Mar 30Valiant Co.,Ltd to Report Q1, 2024 Results on Apr 20, 2024Valiant Co.,Ltd announced that they will report Q1, 2024 results on Apr 20, 2024分析記事 • Mar 22ValiantLtd (SZSE:002643) Has More To Do To Multiply In Value Going ForwardDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'll want...分析記事 • Mar 06Valiant Co.,Ltd's (SZSE:002643) Shares Leap 27% Yet They're Still Not Telling The Full StoryThose holding Valiant Co.,Ltd ( SZSE:002643 ) shares would be relieved that the share price has rebounded 27% in the...分析記事 • Feb 28Is Valiant Co.,Ltd (SZSE:002643) Potentially Undervalued?While Valiant Co.,Ltd ( SZSE:002643 ) might not have the largest market cap around , it received a lot of attention...Valuation Update With 7 Day Price Move • Feb 05Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to CN¥11.78, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 12x in the Chemicals industry in China. Total loss to shareholders of 40% over the past three years.お知らせ • Dec 30Valiant Co.,Ltd to Report Fiscal Year 2023 Results on Apr 20, 2024Valiant Co.,Ltd announced that they will report fiscal year 2023 results on Apr 20, 2024Reported Earnings • Nov 01Third quarter 2023 earnings: EPS exceeds analyst expectationsThird quarter 2023 results: EPS: CN¥0.20 (up from CN¥0.17 in 3Q 2022). Revenue: CN¥1.10b (down 12% from 3Q 2022). Net income: CN¥186.1m (up 22% from 3Q 2022). Profit margin: 17% (up from 12% in 3Q 2022). The increase in margin was driven by lower expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 4.5%. Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.Major Estimate Revision • Oct 30Consensus revenue estimates decrease by 11%The consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast fell from CN¥4.91b to CN¥4.37b. EPS estimate unchanged at CN¥0.881 per share. Net income forecast to grow 47% next year vs 60% growth forecast for Chemicals industry in China. Consensus price target of CN¥23.26 unchanged from last update. Share price rose 8.8% to CN¥16.97 over the past week.お知らせ • Oct 19Valiant Co.,Ltd Announces Board AppointmentsValiant Co.,Ltd held its 2nd Extraordinary General Meeting of 2023 on 17 October 2023, approved the appointment of Zhu Caifei and Zhang Yun as non-independent directors.Reported Earnings • Aug 19Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behindSecond quarter 2023 results: EPS: CN¥0.24 (down from CN¥0.29 in 2Q 2022). Revenue: CN¥1.04b (down 14% from 2Q 2022). Net income: CN¥212.8m (down 18% from 2Q 2022). Profit margin: 20% (in line with 2Q 2022). Revenue missed analyst estimates by 21%. Earnings per share (EPS) exceeded analyst estimates by 6.7%. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.Board Change • Jul 27High number of new and inexperienced directorsThere are 8 new directors who have joined the board in the last 3 years. The company's board is composed of: 8 new directors. 2 experienced directors. 2 highly experienced directors. Member of Supervisory Board Zhenjian Gu is the most experienced director on the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.お知らせ • Jul 23Valiant Co.,Ltd Approves Board ElectionsValiant Co.,Ltd at its Extraordinary General Meeting held on 20 July 2023 approved the election of Tang Meng, Yang Yaowu and Yang Xiaoyue as non-independent directors.Buying Opportunity • Jul 05Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 3.5%. The fair value is estimated to be CN¥21.92, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 16%. Revenue is forecast to grow by 30% in 2 years. Earnings is forecast to grow by 63% in the next 2 years.お知らせ • Jul 01Valiant Co.,Ltd to Report First Half, 2023 Results on Aug 19, 2023Valiant Co.,Ltd announced that they will report first half, 2023 results on Aug 19, 2023Buying Opportunity • Jun 09Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 9.4%. The fair value is estimated to be CN¥20.11, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 16%. Revenue is forecast to grow by 30% in 2 years. Earnings is forecast to grow by 63% in the next 2 years.お知らせ • Jun 03Valiant Co.,Ltd Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 09 June 2023Valiant Co.,Ltd announced final profit distribution plan to be implemented on A shares as cash dividend per ten shares (tax included) of CNY 2.95000000 for the year 2022, payable on 09 June 2023. Record date is 08 June 2023. Ex-date is 09 June 2023.Buying Opportunity • May 16Now 23% undervalued after recent price dropOver the last 90 days, the stock is down 18%. The fair value is estimated to be CN¥20.34, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 16%. Revenue is forecast to grow by 30% in 2 years. Earnings is forecast to grow by 64% in the next 2 years.Reported Earnings • Apr 24First quarter 2023 earnings released: EPS: CN¥0.19 (vs CN¥0.25 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.19 (down from CN¥0.25 in 1Q 2022). Revenue: CN¥1.03b (down 25% from 1Q 2022). Net income: CN¥176.6m (down 24% from 1Q 2022). Profit margin: 17% (in line with 1Q 2022). Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth.Major Estimate Revision • Apr 21Consensus revenue estimates fall by 11%The consensus outlook for revenues in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from CN¥5.80b to CN¥5.14b. EPS estimate fell from CN¥1.10 to CN¥0.923 per share. Net income forecast to grow 9.3% next year vs 38% growth forecast for Chemicals industry in China. Consensus price target broadly unchanged at CN¥22.59. Share price was steady at CN¥17.53 over the past week.Valuation Update With 7 Day Price Move • Feb 01Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥18.82, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 32% over the past three years.お知らせ • Dec 01Valiant Co.,Ltd Approves Election of Lv Shaoyang as DirectorValiant Co.,Ltd announced at the EGM held on November 29, 2022 that the company approved Election of Lv Shaoyang as a director.Board Change • Nov 16High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 2 experienced directors. 3 highly experienced directors. Member of Supervisory Board Tianxiao Hu is the most experienced director on the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Price Target Changed • Nov 03Price target decreased to CN¥23.80Down from CN¥27.68, the current price target is an average from 2 analysts. New target price is 63% above last closing price of CN¥14.63. Stock is down 30% over the past year. The company is forecast to post earnings per share of CN¥0.93 for next year compared to CN¥0.69 last year.Reported Earnings • Oct 28Third quarter 2022 earnings: EPS exceeds analyst expectationsThird quarter 2022 results: EPS: CN¥0.17 (down from CN¥0.21 in 3Q 2021). Revenue: CN¥1.26b (down 11% from 3Q 2021). Net income: CN¥153.0m (down 20% from 3Q 2021). Profit margin: 12% (down from 14% in 3Q 2021). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.Reported Earnings • Aug 21Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behindSecond quarter 2022 results: EPS: CN¥0.29 (up from CN¥0.19 in 2Q 2021). Revenue: CN¥1.22b (up 19% from 2Q 2021). Net income: CN¥258.1m (up 53% from 2Q 2021). Profit margin: 21% (up from 17% in 2Q 2021). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 12%. Earnings per share (EPS) exceeded analyst estimates by 17%. Over the next year, revenue is forecast to grow 14%, compared to a 41% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 16% per year whereas the company’s share price has increased by 18% per year.お知らせ • May 31Valiant Co.,Ltd Announces Cash Dividend, Payable on 06 June 2022Valiant Co.,Ltd announced 2021 final profit distribution plan to be implemented (A shares) as Cash dividend/10 shares (tax included): CNY 2.55000000. Record date as 02 June 2022, ex-date as 06 June 2022 and payment date as 06 June 2022.Board Change • May 29High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Ying Guo was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Valuation Update With 7 Day Price Move • May 04Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥17.85, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 14x in the Chemicals industry in China. Total returns to shareholders of 80% over the past three years.Reported Earnings • Apr 28First quarter 2022 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2022 results: EPS: CN¥0.25 (up from CN¥0.14 in 1Q 2021). Revenue: CN¥1.37b (up 74% from 1Q 2021). Net income: CN¥232.8m (up 77% from 1Q 2021). Profit margin: 17% (in line with 1Q 2021). Revenue exceeded analyst estimates by 3.1%. Earnings per share (EPS) also surpassed analyst estimates by 9.4%. Over the next year, revenue is forecast to grow 16%, compared to a 43% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 12% per year whereas the company’s share price has increased by 14% per year.Board Change • Apr 27High number of new directorsThere are 8 new directors who have joined the board in the last 3 years. Director Wei Li was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.お知らせ • Mar 29+ 1 more updateValiant Co., Ltd. Proposes Final Cash Dividend for the Year 2021Valiant Co., Ltd. proposed final cash dividend/10 shares (tax included) of CNY 2.55000000 for the year 2021.Reported Earnings • Mar 28Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2021 results: EPS: CN¥0.69 (up from CN¥0.56 in FY 2020). Revenue: CN¥4.36b (up 49% from FY 2020). Net income: CN¥626.7m (up 24% from FY 2020). Profit margin: 14% (down from 17% in FY 2020). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 4.3%. Earnings per share (EPS) missed analyst estimates by 7.9%. Over the next year, revenue is forecast to grow 26%, compared to a 47% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 10% per year whereas the company’s share price has increased by 14% per year.Buying Opportunity • Feb 11Now 22% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be CN¥26.17, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% per annum over the last 3 years. Earnings per share has grown by 11% per annum over the last 3 years.Buying Opportunity • Jan 25Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 1.2%. The fair value is estimated to be CN¥26.30, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% per annum over the last 3 years. Earnings per share has grown by 11% per annum over the last 3 years.Valuation Update With 7 Day Price Move • Nov 18Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥24.21, the stock trades at a forward P/E ratio of 27x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 171% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥26.00 per share.Reported Earnings • Oct 26Third quarter 2021 earnings released: EPS CN¥0.21 (vs CN¥0.15 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: CN¥1.42b (up 101% from 3Q 2020). Net income: CN¥191.5m (up 45% from 3Q 2020). Profit margin: 14% (down from 19% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 35% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Sep 29Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to CN¥17.55, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 86% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥26.61 per share.Valuation Update With 7 Day Price Move • Aug 26Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥20.82, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 160% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥24.22 per share.Reported Earnings • Aug 22Second quarter 2021 earnings released: EPS CN¥0.19 (vs CN¥0.10 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: CN¥1.02b (up 77% from 2Q 2020). Net income: CN¥169.3m (up 84% from 2Q 2020). Profit margin: 17% (in line with 2Q 2020). Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 35% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Jul 22Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥18.56, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 140% over the past three years.業績と収益の成長予測SZSE:002643 - アナリストの将来予測と過去の財務データ ( )CNY Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/20285,463668N/AN/A112/31/20274,929570N/A987312/31/20264,299512N/A1,18923/31/20263,8712924411,099N/A12/31/20253,7172843961,090N/A9/30/20253,7572563041,084N/A6/30/20253,607249961,016N/A3/31/20253,617228-25954N/A12/31/20243,693246-121,096N/A9/30/20243,892484-1171,244N/A6/30/20244,188589-1841,239N/A3/31/20244,210685-3231,121N/A12/31/20234,305763-3121,084N/A9/30/20234,412653-336929N/A6/30/20234,567620-406893N/A3/31/20234,742665-345979N/A1/1/20235,080721-312983N/A9/30/20224,977778-238942N/A6/30/20225,135816-66939N/A3/31/20224,94372861896N/A1/1/20224,3596273131,045N/A9/30/20214,1936493031,067N/A6/30/20213,481589135870N/A3/31/20213,036512-29713N/A12/31/20202,918505-100559N/A9/30/20202,87748960670N/A6/30/20202,824492219858N/A3/31/20202,87753088780N/A12/31/20192,870507N/A757N/A9/30/20192,725505N/A664N/A6/30/20192,647482N/A507N/A3/31/20192,636482N/A540N/A12/31/20182,632444N/A431N/A9/30/20182,509389N/A425N/A6/30/20182,472364N/A446N/A3/31/20182,502350N/A451N/A12/31/20172,456385N/A612N/A9/30/20172,320370N/A531N/A6/30/20172,221347N/A455N/A3/31/20172,037328N/A308N/A12/31/20161,847319N/A153N/A9/30/20161,933363N/A211N/A6/30/20161,904373N/A276N/A3/31/20161,788324N/A335N/A12/31/20151,631258N/A367N/A9/30/20151,386179N/A315N/A6/30/20151,251130N/A264N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 002643の予測収益成長率 (年間26.9% ) は 貯蓄率 ( 2.4% ) を上回っています。収益対市場: 002643の収益 ( 26.9% ) CN市場 ( 27.2% ) よりも低い成長が予測されています。高成長収益: 002643の収益は今後 3 年間で 大幅に 増加すると予想されています。収益対市場: 002643の収益 ( 12.7% ) CN市場 ( 16.2% ) よりも低い成長が予測されています。高い収益成長: 002643の収益 ( 12.7% ) 20%よりも低い成長が予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 002643の 自己資本利益率 は、3年後には低くなると予測されています ( 7.5 %)。成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 12:21終値2026/05/22 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Valiant Co.,Ltd 3 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。11 アナリスト機関Xiongwei JiaChina International Capital Corporation LimitedChao LiCitic Securities Co., Ltd.Nai Di ZhaoEverbright Securities Co. Ltd.8 その他のアナリストを表示
Price Target Changed • Feb 03Price target increased by 16% to CN¥18.67Up from CN¥16.10, the current price target is an average from 3 analysts. New target price is 12% above last closing price of CN¥16.73. Stock is up 65% over the past year. The company is forecast to post earnings per share of CN¥0.45 for next year compared to CN¥0.26 last year.
Major Estimate Revision • Aug 23Consensus EPS estimates increase by 17%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate increased from CN¥0.454 to CN¥0.532. Revenue forecast steady at CN¥4.16b. Net income forecast to grow 134% next year vs 48% growth forecast for Chemicals industry in China. Consensus price target up from CN¥14.17 to CN¥15.60. Share price rose 7.4% to CN¥13.99 over the past week.
Price Target Changed • Aug 22Price target increased by 7.4% to CN¥14.77Up from CN¥13.75, the current price target is an average from 3 analysts. New target price is 5.6% above last closing price of CN¥13.99. Stock is up 71% over the past year. The company is forecast to post earnings per share of CN¥0.62 for next year compared to CN¥0.26 last year.
Major Estimate Revision • May 01Consensus revenue estimates fall by 11%The consensus outlook for revenues in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from CN¥4.73b to CN¥4.19b. EPS estimate fell from CN¥0.669 to CN¥0.528 per share. Net income forecast to grow 138% next year vs 49% growth forecast for Chemicals industry in China. Consensus price target up from CN¥13.75 to CN¥14.13. Share price was steady at CN¥10.92 over the past week.
Major Estimate Revision • Nov 23Consensus EPS estimates increase by 26%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has improved. 2024 revenue forecast increased from CN¥3.70b to CN¥3.81b. EPS estimate increased from CN¥0.45 to CN¥0.566 per share. Net income forecast to grow 21% next year vs 53% growth forecast for Chemicals industry in China. Consensus price target of CN¥12.75 unchanged from last update. Share price fell 2.7% to CN¥10.51 over the past week.
Major Estimate Revision • Aug 29Consensus revenue estimates fall by 15%The consensus outlook for revenues in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥4.86b to CN¥4.15b. EPS estimate fell from CN¥0.908 to CN¥0.561 per share. Net income forecast to grow 21% next year vs 45% growth forecast for Chemicals industry in China. Consensus price target down from CN¥18.25 to CN¥13.75. Share price rose 4.4% to CN¥8.35 over the past week.
Reported Earnings • Apr 25First quarter 2026 earnings released: EPS: CN¥0.10 (vs CN¥0.09 in 1Q 2025)First quarter 2026 results: EPS: CN¥0.10 (up from CN¥0.09 in 1Q 2025). Revenue: CN¥1.02b (up 18% from 1Q 2025). Net income: CN¥87.8m (up 10.0% from 1Q 2025). Profit margin: 8.7% (down from 9.3% in 1Q 2025). Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.
お知らせ • Apr 25Valiant Co.,Ltd, Annual General Meeting, May 21, 2026Valiant Co.,Ltd, Annual General Meeting, May 21, 2026, at 14:00 China Standard Time. Location: The Company's Meeting Room, Yantai, Shandong China
お知らせ • Mar 31Valiant Co.,Ltd to Report Q1, 2026 Results on Apr 25, 2026Valiant Co.,Ltd announced that they will report Q1, 2026 results on Apr 25, 2026
Price Target Changed • Feb 03Price target increased by 16% to CN¥18.67Up from CN¥16.10, the current price target is an average from 3 analysts. New target price is 12% above last closing price of CN¥16.73. Stock is up 65% over the past year. The company is forecast to post earnings per share of CN¥0.45 for next year compared to CN¥0.26 last year.
お知らせ • Dec 31Valiant Co.,Ltd to Report Fiscal Year 2025 Results on Apr 25, 2026Valiant Co.,Ltd announced that they will report fiscal year 2025 results on Apr 25, 2026
Reported Earnings • Oct 30Third quarter 2025 earnings: EPS and revenues miss analyst expectationsThird quarter 2025 results: EPS: CN¥0.099 (up from CN¥0.089 in 3Q 2024). Revenue: CN¥956.4m (up 19% from 3Q 2024). Net income: CN¥87.5m (up 8.4% from 3Q 2024). Profit margin: 9.1% (in line with 3Q 2024). Revenue missed analyst estimates by 9.9%. Earnings per share (EPS) also missed analyst estimates by 22%. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.
お知らせ • Sep 30Valiant Co.,Ltd to Report Q3, 2025 Results on Oct 27, 2025Valiant Co.,Ltd announced that they will report Q3, 2025 results on Oct 27, 2025
Reported Earnings • Aug 24Second quarter 2025 earnings: EPS exceeds analyst expectationsSecond quarter 2025 results: EPS: CN¥0.14 (up from CN¥0.12 in 2Q 2024). Revenue: CN¥1.01b (down 1.0% from 2Q 2024). Net income: CN¥138.3m (up 18% from 2Q 2024). Profit margin: 14% (up from 12% in 2Q 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 53%. Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 34% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.
Major Estimate Revision • Aug 23Consensus EPS estimates increase by 17%The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate increased from CN¥0.454 to CN¥0.532. Revenue forecast steady at CN¥4.16b. Net income forecast to grow 134% next year vs 48% growth forecast for Chemicals industry in China. Consensus price target up from CN¥14.17 to CN¥15.60. Share price rose 7.4% to CN¥13.99 over the past week.
Price Target Changed • Aug 22Price target increased by 7.4% to CN¥14.77Up from CN¥13.75, the current price target is an average from 3 analysts. New target price is 5.6% above last closing price of CN¥13.99. Stock is up 71% over the past year. The company is forecast to post earnings per share of CN¥0.62 for next year compared to CN¥0.26 last year.
お知らせ • Jul 02Valiant Co.,Ltd to Report First Half, 2025 Results on Aug 22, 2025Valiant Co.,Ltd announced that they will report first half, 2025 results on Aug 22, 2025
Declared Dividend • Jun 01Dividend reduced to CN¥0.10Dividend of CN¥0.10 is 67% lower than last year. Ex-date: 6th June 2025 Payment date: 6th June 2025 Dividend yield will be 0.9%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (42% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 3.3% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 139% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Major Estimate Revision • May 01Consensus revenue estimates fall by 11%The consensus outlook for revenues in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from CN¥4.73b to CN¥4.19b. EPS estimate fell from CN¥0.669 to CN¥0.528 per share. Net income forecast to grow 138% next year vs 49% growth forecast for Chemicals industry in China. Consensus price target up from CN¥13.75 to CN¥14.13. Share price was steady at CN¥10.92 over the past week.
Board Change • Apr 30High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Chairman of the Supervisory Board Lei Zhang was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Apr 27Valiant Co.,Ltd (SZSE:002643) announces an Equity Buyback for CNY 200 million worth of its shares.Valiant Co.,Ltd (SZSE:002643) announces a share repurchase program. Under the program, the company will repurchase up to CNY 200 million worth of class A common shares. The shares will be repurchased at a purchase price of CNY 16.55 per share. The purpose of the program is to reduce the company's registered capital. The program will be valid for 12 months.
Reported Earnings • Apr 25First quarter 2025 earnings released: EPS: CN¥0.09 (vs CN¥0.11 in 1Q 2024)First quarter 2025 results: EPS: CN¥0.09 (down from CN¥0.11 in 1Q 2024). Revenue: CN¥861.2m (down 8.2% from 1Q 2024). Net income: CN¥79.9m (down 19% from 1Q 2024). Profit margin: 9.3% (down from 11% in 1Q 2024). Revenue is forecast to grow 23% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings.
お知らせ • Apr 25Valiant Co.,Ltd, Annual General Meeting, May 21, 2025Valiant Co.,Ltd, Annual General Meeting, May 21, 2025, at 14:00 China Standard Time. Location: The Company's Meeting Room, Yantai, Shandong China
Buy Or Sell Opportunity • Apr 04Now 21% undervaluedOver the last 90 days, the stock has risen 3.7% to CN¥10.99. The fair value is estimated to be CN¥13.93, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 4.7% over the last 3 years. Earnings per share has declined by 6.5%. Revenue is forecast to grow by 36% in 2 years. Earnings are forecast to grow by 49% in the next 2 years.
お知らせ • Mar 31Valiant Co.,Ltd to Report Q1, 2025 Results on Apr 25, 2025Valiant Co.,Ltd announced that they will report Q1, 2025 results on Apr 25, 2025
分析記事 • Mar 25Valiant Co.,Ltd's (SZSE:002643) Share Price Is Matching Sentiment Around Its EarningsValiant Co.,Ltd's ( SZSE:002643 ) price-to-earnings (or "P/E") ratio of 21.4x might make it look like a buy right now...
分析記事 • Mar 07There Are Reasons To Feel Uneasy About ValiantLtd's (SZSE:002643) Returns On CapitalIf you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
分析記事 • Feb 21We Think ValiantLtd (SZSE:002643) Is Taking Some Risk With Its DebtDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Buy Or Sell Opportunity • Feb 13Now 20% undervaluedThe stock has been flat over the last 90 days, currently trading at CN¥10.79. The fair value is estimated to be CN¥13.55, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 4.7% over the last 3 years. Earnings per share has declined by 6.5%. Revenue is forecast to grow by 36% in 2 years. Earnings are forecast to grow by 49% in the next 2 years.
Valuation Update With 7 Day Price Move • Jan 03Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥10.60, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 18x in the Chemicals industry in China. Total loss to shareholders of 48% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥14.59 per share.
Buy Or Sell Opportunity • Jan 02Now 24% undervaluedOver the last 90 days, the stock has risen 9.0% to CN¥11.30. The fair value is estimated to be CN¥14.79, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 4.7% over the last 3 years. Earnings per share has declined by 6.5%. Revenue is forecast to grow by 36% in 2 years. Earnings are forecast to grow by 49% in the next 2 years.
お知らせ • Dec 31Valiant Co.,Ltd to Report Fiscal Year 2024 Results on Apr 25, 2025Valiant Co.,Ltd announced that they will report fiscal year 2024 results on Apr 25, 2025
分析記事 • Dec 18Calculating The Fair Value Of Valiant Co.,Ltd (SZSE:002643)Key Insights Using the 2 Stage Free Cash Flow to Equity, ValiantLtd fair value estimate is CN¥14.68 Current share price...
分析記事 • Dec 04Valiant Co.,Ltd's (SZSE:002643) Shares Bounce 31% But Its Business Still Trails The MarketValiant Co.,Ltd ( SZSE:002643 ) shares have continued their recent momentum with a 31% gain in the last month alone...
Valuation Update With 7 Day Price Move • Dec 03Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥12.42, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 20x in the Chemicals industry in China. Total loss to shareholders of 44% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥14.52 per share.
分析記事 • Nov 26ValiantLtd (SZSE:002643) Could Be Struggling To Allocate CapitalIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
Major Estimate Revision • Nov 23Consensus EPS estimates increase by 26%The consensus outlook for earnings per share (EPS) in fiscal year 2024 has improved. 2024 revenue forecast increased from CN¥3.70b to CN¥3.81b. EPS estimate increased from CN¥0.45 to CN¥0.566 per share. Net income forecast to grow 21% next year vs 53% growth forecast for Chemicals industry in China. Consensus price target of CN¥12.75 unchanged from last update. Share price fell 2.7% to CN¥10.51 over the past week.
Buy Or Sell Opportunity • Nov 13Now 20% undervaluedOver the last 90 days, the stock has risen 28% to CN¥11.55. The fair value is estimated to be CN¥14.47, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 4.7% over the last 3 years. Earnings per share has declined by 6.5%. Revenue is forecast to grow by 33% in 2 years. Earnings are forecast to grow by 63% in the next 2 years.
分析記事 • Nov 05ValiantLtd's (SZSE:002643) Shareholders Have More To Worry About Than Only Soft EarningsThe market wasn't impressed with the soft earnings from Valiant Co.,Ltd ( SZSE:002643 ) recently. We did some analysis...
Reported Earnings • Oct 30Third quarter 2024 earnings: EPS and revenues miss analyst expectationsThird quarter 2024 results: EPS: CN¥0.089 (down from CN¥0.20 in 3Q 2023). Revenue: CN¥806.3m (down 27% from 3Q 2023). Net income: CN¥80.7m (down 57% from 3Q 2023). Profit margin: 10.0% (down from 17% in 3Q 2023). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 23%. Earnings per share (EPS) also missed analyst estimates by 50%. Revenue is forecast to grow 19% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has fallen by 20% per year, which means it is performing significantly worse than earnings.
Buy Or Sell Opportunity • Oct 11Now 20% undervaluedOver the last 90 days, the stock has risen 2.1% to CN¥9.77. The fair value is estimated to be CN¥12.28, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue is forecast to grow by 33% in 2 years. Earnings are forecast to grow by 51% in the next 2 years.
分析記事 • Oct 08Valiant Co.,Ltd's (SZSE:002643) Shares Bounce 40% But Its Business Still Trails The MarketValiant Co.,Ltd ( SZSE:002643 ) shares have had a really impressive month, gaining 40% after a shaky period beforehand...
お知らせ • Sep 30Valiant Co.,Ltd to Report Q3, 2024 Results on Oct 30, 2024Valiant Co.,Ltd announced that they will report Q3, 2024 results on Oct 30, 2024
Valuation Update With 7 Day Price Move • Sep 27Investor sentiment improves as stock rises 20%After last week's 20% share price gain to CN¥9.43, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 47% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥12.08 per share.
分析記事 • Sep 05Are Investors Undervaluing Valiant Co.,Ltd (SZSE:002643) By 30%?Key Insights Using the 2 Stage Free Cash Flow to Equity, ValiantLtd fair value estimate is CN¥12.10 ValiantLtd's...
Major Estimate Revision • Aug 29Consensus revenue estimates fall by 15%The consensus outlook for revenues in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥4.86b to CN¥4.15b. EPS estimate fell from CN¥0.908 to CN¥0.561 per share. Net income forecast to grow 21% next year vs 45% growth forecast for Chemicals industry in China. Consensus price target down from CN¥18.25 to CN¥13.75. Share price rose 4.4% to CN¥8.35 over the past week.
Price Target Changed • Aug 27Price target decreased by 9.2% to CN¥16.63Down from CN¥18.31, the current price target is an average from 4 analysts. New target price is 107% above last closing price of CN¥8.03. Stock is down 54% over the past year. The company is forecast to post earnings per share of CN¥0.90 for next year compared to CN¥0.84 last year.
Reported Earnings • Aug 22Second quarter 2024 earnings: EPS and revenues miss analyst expectationsSecond quarter 2024 results: EPS: CN¥0.12 (down from CN¥0.24 in 2Q 2023). Revenue: CN¥1.02b (down 2.2% from 2Q 2023). Net income: CN¥116.9m (down 45% from 2Q 2023). Profit margin: 12% (down from 20% in 2Q 2023). The decrease in margin was primarily driven by higher expenses. Revenue missed analyst estimates by 26%. Earnings per share (EPS) also missed analyst estimates by 46%. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has fallen by 27% per year, which means it is significantly lagging earnings.
分析記事 • Aug 19Lacklustre Performance Is Driving Valiant Co.,Ltd's (SZSE:002643) Low P/EWith a price-to-earnings (or "P/E") ratio of 11.7x Valiant Co.,Ltd ( SZSE:002643 ) may be sending very bullish signals...
分析記事 • Jul 18We Think ValiantLtd (SZSE:002643) Can Stay On Top Of Its DebtWarren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
お知らせ • Jun 29Valiant Co.,Ltd to Report First Half, 2024 Results on Aug 22, 2024Valiant Co.,Ltd announced that they will report first half, 2024 results on Aug 22, 2024
分析記事 • Jun 21Return Trends At ValiantLtd (SZSE:002643) Aren't AppealingTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Amongst other things...
分析記事 • Jun 02ValiantLtd (SZSE:002643) Has Announced That It Will Be Increasing Its Dividend To CN¥0.30Valiant Co.,Ltd ( SZSE:002643 ) will increase its dividend on the 6th of June to CN¥0.30, which is 1.7% higher than...
Declared Dividend • Jun 01Dividend of CN¥0.30 announcedShareholders will receive a dividend of CN¥0.30. Ex-date: 6th June 2024 Payment date: 6th June 2024 Dividend yield will be 2.6%, which is about the same as the industry average. Sustainability & Growth Dividend is covered by earnings (39% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 15% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 61% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
お知らせ • May 31Valiant Co.,Ltd Announces 2023 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on 06 June 2024Valiant Co.,Ltd announced 2023 final profit distribution plan to be implemented (A shares) of Cash dividend/10 shares (tax included) is CNY 3.00000000, Record date is 05 June 2024, Ex-date: 06 June 2024, Payment date is 06 June 2024.
Major Estimate Revision • May 23Consensus EPS estimates increase by 14%The consensus outlook for fiscal year 2024 has been updated. 2024 consensus EPS increased from CN¥0.831 to CN¥0.947. Revenues were reaffirmed at CN¥4.86b. Net income forecast to grow 36% next year vs 52% growth forecast for Chemicals industry in China. Consensus price target broadly unchanged at CN¥18.25. Share price was steady at CN¥11.44 over the past week.
分析記事 • Apr 26Solid Earnings May Not Tell The Whole Story For ValiantLtd (SZSE:002643)The stock price didn't jump after Valiant Co.,Ltd ( SZSE:002643 ) posted decent earnings last week. We did some digging...
Major Estimate Revision • Apr 26Consensus revenue estimates fall by 13%The consensus outlook for revenues in fiscal year 2024 has deteriorated. 2024 revenue forecast decreased from CN¥5.58b to CN¥4.86b. EPS estimate fell from CN¥1.04 to CN¥0.831 per share. Net income forecast to grow 21% next year vs 39% growth forecast for Chemicals industry in China. Consensus price target down from CN¥20.64 to CN¥18.31. Share price fell 8.4% to CN¥11.31 over the past week.
分析記事 • Apr 23What Does The Future Hold For Valiant Co.,Ltd (SZSE:002643)? These Analysts Have Been Cutting Their EstimatesThe analysts covering Valiant Co.,Ltd ( SZSE:002643 ) delivered a dose of negativity to shareholders today, by making a...
Price Target Changed • Apr 22Price target decreased by 7.3% to CN¥19.14Down from CN¥20.64, the current price target is an average from 4 analysts. New target price is 72% above last closing price of CN¥11.12. Stock is down 36% over the past year. The company is forecast to post earnings per share of CN¥0.98 for next year compared to CN¥0.84 last year.
お知らせ • Apr 21Valiant Co.,Ltd, Annual General Meeting, May 16, 2024Valiant Co.,Ltd, Annual General Meeting, May 16, 2024, at 14:00 China Standard Time. Location: The Company's Meeting Room, Yantai, Shandong China
Reported Earnings • Apr 20First quarter 2024 earnings released: EPS: CN¥0.11 (vs CN¥0.19 in 1Q 2023)First quarter 2024 results: EPS: CN¥0.11 (down from CN¥0.19 in 1Q 2023). Revenue: CN¥937.9m (down 9.2% from 1Q 2023). Net income: CN¥98.3m (down 44% from 1Q 2023). Profit margin: 11% (down from 17% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 23% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings.
Price Target Changed • Apr 08Price target decreased by 12% to CN¥20.64Down from CN¥23.54, the current price target is an average from 4 analysts. New target price is 58% above last closing price of CN¥13.02. Stock is down 26% over the past year. The company is forecast to post earnings per share of CN¥0.85 for next year compared to CN¥0.79 last year.
お知らせ • Mar 30Valiant Co.,Ltd to Report Q1, 2024 Results on Apr 20, 2024Valiant Co.,Ltd announced that they will report Q1, 2024 results on Apr 20, 2024
分析記事 • Mar 22ValiantLtd (SZSE:002643) Has More To Do To Multiply In Value Going ForwardDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'll want...
分析記事 • Mar 06Valiant Co.,Ltd's (SZSE:002643) Shares Leap 27% Yet They're Still Not Telling The Full StoryThose holding Valiant Co.,Ltd ( SZSE:002643 ) shares would be relieved that the share price has rebounded 27% in the...
分析記事 • Feb 28Is Valiant Co.,Ltd (SZSE:002643) Potentially Undervalued?While Valiant Co.,Ltd ( SZSE:002643 ) might not have the largest market cap around , it received a lot of attention...
Valuation Update With 7 Day Price Move • Feb 05Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to CN¥11.78, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 12x in the Chemicals industry in China. Total loss to shareholders of 40% over the past three years.
お知らせ • Dec 30Valiant Co.,Ltd to Report Fiscal Year 2023 Results on Apr 20, 2024Valiant Co.,Ltd announced that they will report fiscal year 2023 results on Apr 20, 2024
Reported Earnings • Nov 01Third quarter 2023 earnings: EPS exceeds analyst expectationsThird quarter 2023 results: EPS: CN¥0.20 (up from CN¥0.17 in 3Q 2022). Revenue: CN¥1.10b (down 12% from 3Q 2022). Net income: CN¥186.1m (up 22% from 3Q 2022). Profit margin: 17% (up from 12% in 3Q 2022). The increase in margin was driven by lower expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 4.5%. Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.
Major Estimate Revision • Oct 30Consensus revenue estimates decrease by 11%The consensus outlook for fiscal year 2023 has been updated. 2023 revenue forecast fell from CN¥4.91b to CN¥4.37b. EPS estimate unchanged at CN¥0.881 per share. Net income forecast to grow 47% next year vs 60% growth forecast for Chemicals industry in China. Consensus price target of CN¥23.26 unchanged from last update. Share price rose 8.8% to CN¥16.97 over the past week.
お知らせ • Oct 19Valiant Co.,Ltd Announces Board AppointmentsValiant Co.,Ltd held its 2nd Extraordinary General Meeting of 2023 on 17 October 2023, approved the appointment of Zhu Caifei and Zhang Yun as non-independent directors.
Reported Earnings • Aug 19Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behindSecond quarter 2023 results: EPS: CN¥0.24 (down from CN¥0.29 in 2Q 2022). Revenue: CN¥1.04b (down 14% from 2Q 2022). Net income: CN¥212.8m (down 18% from 2Q 2022). Profit margin: 20% (in line with 2Q 2022). Revenue missed analyst estimates by 21%. Earnings per share (EPS) exceeded analyst estimates by 6.7%. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.
Board Change • Jul 27High number of new and inexperienced directorsThere are 8 new directors who have joined the board in the last 3 years. The company's board is composed of: 8 new directors. 2 experienced directors. 2 highly experienced directors. Member of Supervisory Board Zhenjian Gu is the most experienced director on the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
お知らせ • Jul 23Valiant Co.,Ltd Approves Board ElectionsValiant Co.,Ltd at its Extraordinary General Meeting held on 20 July 2023 approved the election of Tang Meng, Yang Yaowu and Yang Xiaoyue as non-independent directors.
Buying Opportunity • Jul 05Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 3.5%. The fair value is estimated to be CN¥21.92, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 16%. Revenue is forecast to grow by 30% in 2 years. Earnings is forecast to grow by 63% in the next 2 years.
お知らせ • Jul 01Valiant Co.,Ltd to Report First Half, 2023 Results on Aug 19, 2023Valiant Co.,Ltd announced that they will report first half, 2023 results on Aug 19, 2023
Buying Opportunity • Jun 09Now 22% undervalued after recent price dropOver the last 90 days, the stock is down 9.4%. The fair value is estimated to be CN¥20.11, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 16%. Revenue is forecast to grow by 30% in 2 years. Earnings is forecast to grow by 63% in the next 2 years.
お知らせ • Jun 03Valiant Co.,Ltd Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 09 June 2023Valiant Co.,Ltd announced final profit distribution plan to be implemented on A shares as cash dividend per ten shares (tax included) of CNY 2.95000000 for the year 2022, payable on 09 June 2023. Record date is 08 June 2023. Ex-date is 09 June 2023.
Buying Opportunity • May 16Now 23% undervalued after recent price dropOver the last 90 days, the stock is down 18%. The fair value is estimated to be CN¥20.34, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 23% over the last 3 years. Earnings per share has grown by 16%. Revenue is forecast to grow by 30% in 2 years. Earnings is forecast to grow by 64% in the next 2 years.
Reported Earnings • Apr 24First quarter 2023 earnings released: EPS: CN¥0.19 (vs CN¥0.25 in 1Q 2022)First quarter 2023 results: EPS: CN¥0.19 (down from CN¥0.25 in 1Q 2022). Revenue: CN¥1.03b (down 25% from 1Q 2022). Net income: CN¥176.6m (down 24% from 1Q 2022). Profit margin: 17% (in line with 1Q 2022). Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth.
Major Estimate Revision • Apr 21Consensus revenue estimates fall by 11%The consensus outlook for revenues in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from CN¥5.80b to CN¥5.14b. EPS estimate fell from CN¥1.10 to CN¥0.923 per share. Net income forecast to grow 9.3% next year vs 38% growth forecast for Chemicals industry in China. Consensus price target broadly unchanged at CN¥22.59. Share price was steady at CN¥17.53 over the past week.
Valuation Update With 7 Day Price Move • Feb 01Investor sentiment improves as stock rises 17%After last week's 17% share price gain to CN¥18.82, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 32% over the past three years.
お知らせ • Dec 01Valiant Co.,Ltd Approves Election of Lv Shaoyang as DirectorValiant Co.,Ltd announced at the EGM held on November 29, 2022 that the company approved Election of Lv Shaoyang as a director.
Board Change • Nov 16High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. 2 experienced directors. 3 highly experienced directors. Member of Supervisory Board Tianxiao Hu is the most experienced director on the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Price Target Changed • Nov 03Price target decreased to CN¥23.80Down from CN¥27.68, the current price target is an average from 2 analysts. New target price is 63% above last closing price of CN¥14.63. Stock is down 30% over the past year. The company is forecast to post earnings per share of CN¥0.93 for next year compared to CN¥0.69 last year.
Reported Earnings • Oct 28Third quarter 2022 earnings: EPS exceeds analyst expectationsThird quarter 2022 results: EPS: CN¥0.17 (down from CN¥0.21 in 3Q 2021). Revenue: CN¥1.26b (down 11% from 3Q 2021). Net income: CN¥153.0m (down 20% from 3Q 2021). Profit margin: 12% (down from 14% in 3Q 2021). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Aug 21Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behindSecond quarter 2022 results: EPS: CN¥0.29 (up from CN¥0.19 in 2Q 2021). Revenue: CN¥1.22b (up 19% from 2Q 2021). Net income: CN¥258.1m (up 53% from 2Q 2021). Profit margin: 21% (up from 17% in 2Q 2021). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 12%. Earnings per share (EPS) exceeded analyst estimates by 17%. Over the next year, revenue is forecast to grow 14%, compared to a 41% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 16% per year whereas the company’s share price has increased by 18% per year.
お知らせ • May 31Valiant Co.,Ltd Announces Cash Dividend, Payable on 06 June 2022Valiant Co.,Ltd announced 2021 final profit distribution plan to be implemented (A shares) as Cash dividend/10 shares (tax included): CNY 2.55000000. Record date as 02 June 2022, ex-date as 06 June 2022 and payment date as 06 June 2022.
Board Change • May 29High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Ying Guo was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Valuation Update With 7 Day Price Move • May 04Investor sentiment improved over the past weekAfter last week's 17% share price gain to CN¥17.85, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 14x in the Chemicals industry in China. Total returns to shareholders of 80% over the past three years.
Reported Earnings • Apr 28First quarter 2022 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2022 results: EPS: CN¥0.25 (up from CN¥0.14 in 1Q 2021). Revenue: CN¥1.37b (up 74% from 1Q 2021). Net income: CN¥232.8m (up 77% from 1Q 2021). Profit margin: 17% (in line with 1Q 2021). Revenue exceeded analyst estimates by 3.1%. Earnings per share (EPS) also surpassed analyst estimates by 9.4%. Over the next year, revenue is forecast to grow 16%, compared to a 43% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 12% per year whereas the company’s share price has increased by 14% per year.
Board Change • Apr 27High number of new directorsThere are 8 new directors who have joined the board in the last 3 years. Director Wei Li was the last director to join the board, commencing their role in 2021. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Mar 29+ 1 more updateValiant Co., Ltd. Proposes Final Cash Dividend for the Year 2021Valiant Co., Ltd. proposed final cash dividend/10 shares (tax included) of CNY 2.55000000 for the year 2021.
Reported Earnings • Mar 28Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2021 results: EPS: CN¥0.69 (up from CN¥0.56 in FY 2020). Revenue: CN¥4.36b (up 49% from FY 2020). Net income: CN¥626.7m (up 24% from FY 2020). Profit margin: 14% (down from 17% in FY 2020). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 4.3%. Earnings per share (EPS) missed analyst estimates by 7.9%. Over the next year, revenue is forecast to grow 26%, compared to a 47% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 10% per year whereas the company’s share price has increased by 14% per year.
Buying Opportunity • Feb 11Now 22% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be CN¥26.17, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% per annum over the last 3 years. Earnings per share has grown by 11% per annum over the last 3 years.
Buying Opportunity • Jan 25Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 1.2%. The fair value is estimated to be CN¥26.30, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% per annum over the last 3 years. Earnings per share has grown by 11% per annum over the last 3 years.
Valuation Update With 7 Day Price Move • Nov 18Investor sentiment improved over the past weekAfter last week's 18% share price gain to CN¥24.21, the stock trades at a forward P/E ratio of 27x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 171% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥26.00 per share.
Reported Earnings • Oct 26Third quarter 2021 earnings released: EPS CN¥0.21 (vs CN¥0.15 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: CN¥1.42b (up 101% from 3Q 2020). Net income: CN¥191.5m (up 45% from 3Q 2020). Profit margin: 14% (down from 19% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 35% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Sep 29Investor sentiment deteriorated over the past weekAfter last week's 18% share price decline to CN¥17.55, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 86% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥26.61 per share.
Valuation Update With 7 Day Price Move • Aug 26Investor sentiment improved over the past weekAfter last week's 15% share price gain to CN¥20.82, the stock trades at a forward P/E ratio of 25x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 160% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥24.22 per share.
Reported Earnings • Aug 22Second quarter 2021 earnings released: EPS CN¥0.19 (vs CN¥0.10 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: CN¥1.02b (up 77% from 2Q 2020). Net income: CN¥169.3m (up 84% from 2Q 2020). Profit margin: 17% (in line with 2Q 2020). Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 35% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Jul 22Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥18.56, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 140% over the past three years.